Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
41
GFS Quote, Financials, Valuation and Earnings
Last price:
$43.70
Seasonality move
:
9.12%
Day range:
$40.50 - $42.66
52-week range:
$35.85 - $62.61
Dividend yield:
0%
P/E ratio:
31.13x
P/S ratio:
3.43x
P/B ratio:
2.05x
Volume:
3.5M
Avg. volume:
1.7M
1-year change:
-28.12%
Market cap:
$23.1B
Revenue:
$7.4B
EPS (TTM):
$1.34
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.8B | $4.9B | $6.6B | $8.1B | $7.4B | |
| Revenue Growth (YoY) | -6.19% | -16.55% | 35.75% | 23.13% | -8.83% | |
| Cost of Revenues | $6.3B | $5.6B | $5.6B | $5.9B | $5.3B | |
| Gross Profit | -$532.2M | -$712M | $1B | $2.2B | $2.1B | |
| Gross Profit Margin | -9.16% | -14.68% | 15.38% | 27.62% | 28.42% | |
| R&D Expenses | $583M | $476M | $478M | $482M | $428M | |
| Selling, General & Admin | $358.9M | $330M | $546M | $451M | $448M | |
| Other Inc / (Exp) | $632.5M | $419M | -$8M | $331M | -$128M | |
| Operating Expenses | $1B | $921M | $1.1B | $978M | $901M | |
| Operating Income | -$1.6B | -$1.6B | -$60M | $1.3B | $1.2B | |
| Net Interest Expenses | $218.8M | $151M | $108M | $60M | -- | |
| EBT. Incl. Unusual Items | -$1.1B | -$1.4B | -$176M | $1.5B | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $224.1M | -$12M | $78M | $86M | $66M | |
| Net Income to Company | -$1.4B | -$1.4B | -$254M | $1.4B | $1B | |
| Minority Interest in Earnings | -- | $3M | $4M | $2M | $2M | |
| Net Income to Common Excl Extra Items | -$1.4B | -$1.4B | -$250M | $1.4B | $1B | |
| Basic EPS (Cont. Ops) | -$2.58 | -$2.54 | -$0.49 | $2.69 | $1.85 | |
| Diluted EPS (Cont. Ops) | -$2.58 | -$2.54 | -$0.49 | $2.62 | $1.83 | |
| Weighted Average Basic Share | $531.8M | $531.8M | $506M | $539M | $552M | |
| Weighted Average Diluted Share | $531.8M | $531.8M | $506M | $552M | $556M | |
| EBITDA | $1.7B | $1.3B | $1.5B | $3.2B | $2.6B | |
| EBIT | -$944.3M | -$1.2B | -$77M | $1.6B | $1.2B | |
| Revenue (Reported) | $5.8B | $4.9B | $6.6B | $8.1B | $7.4B | |
| Operating Income (Reported) | -$1.6B | -$1.6B | -$60M | $1.3B | $1.2B | |
| Operating Income (Adjusted) | -$944.3M | -$1.2B | -$77M | $1.6B | $1.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.7B | $2.1B | $1.9B | $1.7B | |
| Revenue Growth (YoY) | -- | 55.82% | 22% | -10.7% | -6.1% | |
| Cost of Revenues | $1.2B | $1.4B | $1.5B | $1.3B | $1.3B | |
| Gross Profit | -$134M | $300M | $610M | $529M | $414M | |
| Gross Profit Margin | -12.28% | 17.65% | 29.41% | 28.56% | 23.81% | |
| R&D Expenses | $117M | $114M | $124M | $108M | $130M | |
| Selling, General & Admin | $99M | $134M | $129M | $143M | $98M | |
| Other Inc / (Exp) | $35M | $2M | $9M | -$38M | -$6M | |
| Operating Expenses | $216M | $248M | $253M | $251M | $228M | |
| Operating Income | -$350M | $52M | $357M | $278M | $186M | |
| Net Interest Expenses | $34M | $27M | $11M | -- | -- | |
| EBT. Incl. Unusual Items | -$349M | $27M | $355M | $243M | $195M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$56M | $22M | $19M | -$6M | $17M | |
| Net Income to Company | -- | $5M | $336M | $249M | $178M | |
| Minority Interest in Earnings | -- | $1M | $1M | -- | -$1M | |
| Net Income to Common Excl Extra Items | -$293M | $6M | $337M | $249M | $177M | |
| Basic EPS (Cont. Ops) | -$0.55 | $0.01 | $0.62 | $0.45 | $0.32 | |
| Diluted EPS (Cont. Ops) | -$0.55 | $0.01 | $0.61 | $0.45 | $0.32 | |
| Weighted Average Basic Share | $531.8M | $534.7M | $543M | $553M | $552M | |
| Weighted Average Diluted Share | $531.8M | $534.7M | $553M | $556M | $555M | |
| EBITDA | $297M | $469M | $752M | $644M | $582M | |
| EBIT | -$315M | $54M | $357M | $278M | $186M | |
| Revenue (Reported) | $1.1B | $1.7B | $2.1B | $1.9B | $1.7B | |
| Operating Income (Reported) | -$350M | $52M | $357M | $278M | $186M | |
| Operating Income (Adjusted) | -$315M | $54M | $357M | $278M | $186M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $5.8B | $7.9B | $7.6B | $6.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $5.4B | $5.9B | $5.4B | $5B | |
| Gross Profit | -- | $412.6M | $2B | $2.2B | $1.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $464.8M | $502M | $433M | $480M | |
| Selling, General & Admin | -- | $448.4M | $533M | $516M | $396M | |
| Other Inc / (Exp) | $35M | -$25.5M | $43M | $210M | -$59M | |
| Operating Expenses | -- | $1B | $1B | $949M | $901M | |
| Operating Income | -- | -$615.6M | $966M | $1.2B | $826M | |
| Net Interest Expenses | $34M | $119.9M | $84M | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$761M | $925M | $1.5B | $816M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $61.4M | $104M | $53M | $71M | |
| Net Income to Company | -- | -- | $820M | $1.4B | $745M | |
| Minority Interest in Earnings | -- | $3M | $3M | $3M | -$3M | |
| Net Income to Common Excl Extra Items | -- | -$817.7M | $824M | $1.4B | $742M | |
| Basic EPS (Cont. Ops) | -- | -$1.54 | $1.53 | $2.56 | $1.34 | |
| Diluted EPS (Cont. Ops) | -- | -$1.54 | $1.50 | $2.55 | $1.34 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | $1.2B | $2.6B | $3B | $2.4B | |
| EBIT | -- | -$661.3M | $984M | $1.5B | $811M | |
| Revenue (Reported) | -- | $5.8B | $7.9B | $7.6B | $6.8B | |
| Operating Income (Reported) | -- | -$615.6M | $966M | $1.2B | $826M | |
| Operating Income (Adjusted) | -- | -$661.3M | $984M | $1.5B | $811M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $4.7B | $6B | $5.5B | $4.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.2B | $4.1B | $4.4B | $4B | $3.7B | |
| Gross Profit | -$134M | $630M | $1.6B | $1.6B | $1.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $117M | $349M | $372M | $323M | $375M | |
| Selling, General & Admin | $99M | $427M | $366M | $386M | $334M | |
| Other Inc / (Exp) | $35M | -$14M | $35M | -$86M | -$17M | |
| Operating Expenses | $216M | $776M | $738M | $709M | $709M | |
| Operating Income | -$350M | -$146M | $879M | $867M | $493M | |
| Net Interest Expenses | $34M | $83M | $58M | -- | -- | |
| EBT. Incl. Unusual Items | -$349M | -$243M | $856M | $785M | $517M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$56M | $53M | $78M | $45M | $50M | |
| Net Income to Company | -- | -$296M | $778M | $740M | $467M | |
| Minority Interest in Earnings | -- | $3M | $2M | $3M | -$2M | |
| Net Income to Common Excl Extra Items | -$293M | -$293M | $780M | $743M | $465M | |
| Basic EPS (Cont. Ops) | -$0.55 | -$0.55 | $1.45 | $1.34 | $0.84 | |
| Diluted EPS (Cont. Ops) | -$0.55 | -$0.55 | $1.42 | $1.34 | $0.84 | |
| Weighted Average Basic Share | $531.8M | $1.6B | $1.6B | $1.7B | $1.7B | |
| Weighted Average Diluted Share | $531.8M | $1.6B | $1.7B | $1.7B | $1.7B | |
| EBITDA | $297M | $1B | $2.1B | $1.9B | $1.7B | |
| EBIT | -$315M | -$160M | $889M | $867M | $493M | |
| Revenue (Reported) | $1.1B | $4.7B | $6B | $5.5B | $4.9B | |
| Operating Income (Reported) | -$350M | -$146M | $879M | $867M | $493M | |
| Operating Income (Adjusted) | -$315M | -$160M | $889M | $867M | $493M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $997.3M | $908.1M | $2.9B | $2.4B | $2.4B | |
| Short Term Investments | -- | -- | $23M | $701M | $1.1B | |
| Accounts Receivable, Net | $647M | $767.3M | $872M | $824M | $1B | |
| Inventory | $351.9M | $919.5M | $1.1B | $1.3B | $1.5B | |
| Prepaid Expenses | $44M | -- | -- | -- | -- | |
| Other Current Assets | $12M | -- | -- | -- | -- | |
| Total Current Assets | $3.5B | $3B | $5.3B | $5.8B | $6.3B | |
| Property Plant And Equipment | $9.6B | $8.2B | $8.7B | $10.6B | $10.2B | |
| Long-Term Investments | $85.5M | $36.7M | -- | $509M | $578M | |
| Goodwill | $5.5M | $18M | $18M | $18M | $18M | |
| Other Intangibles | $629.3M | $529.9M | $359M | $345M | $373M | |
| Other Long-Term Assets | $39M | $14.4M | $34M | $25M | $24M | |
| Total Assets | $14.5B | $12.3B | $15B | $17.8B | $18B | |
| Accounts Payable | -- | $414.5M | $551M | $532M | $511M | |
| Accrued Expenses | $558.8M | $470.8M | $603M | $573M | $496M | |
| Current Portion Of Long-Term Debt | $686.9M | $381.8M | $297M | $223M | $571M | |
| Current Portion Of Capital Lease Obligations | $130.9M | $131.3M | $135M | $75M | $32M | |
| Other Current Liabilities | $9.3M | $48.9M | $118M | $98M | $97M | |
| Total Current Liabilities | $2.3B | $1.9B | $3.2B | $3.4B | $3.1B | |
| Long-Term Debt | $2B | $2B | $1.7B | $2.3B | $1.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.5B | $5.1B | $7B | $7.9B | $6.9B | |
| Common Stock | $10M | $10M | $11M | $11M | $11M | |
| Other Common Equity Adj | $5.8M | -$3.3M | -$54M | $92M | $67M | |
| Common Equity | $9B | $7.2B | $8B | $9.9B | $11.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $65.1M | $58M | $47M | $47M | |
| Total Equity | $9B | $7.2B | $8B | $10B | $11.2B | |
| Total Liabilities and Equity | $14.5B | $12.3B | $15B | $17.8B | $18B | |
| Cash and Short Terms | $997.3M | $908.1M | $3B | $3.1B | $3.5B | |
| Total Debt | $2.7B | $2.3B | $2B | $2.5B | $2.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $1B | $2.5B | $1.9B | -- | |
| Short Term Investments | -- | -- | $567M | $1B | -- | |
| Accounts Receivable, Net | -- | -- | $798M | $1B | -- | |
| Inventory | -- | $1.1B | $1.3B | $1.5B | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $3.2B | $5.6B | $5.8B | -- | |
| Property Plant And Equipment | -- | $8.5B | $10.2B | $10.6B | -- | |
| Long-Term Investments | -- | -- | $478M | $568M | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | $627M | $41M | $24M | -- | |
| Total Assets | -- | $12.6B | $17.2B | $17.8B | -- | |
| Accounts Payable | -- | -- | $3.4B | $2.3B | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $371M | $207M | $199M | -- | |
| Current Portion Of Capital Lease Obligations | -- | $95M | $148M | $52M | -- | |
| Other Current Liabilities | -- | $2B | -- | -- | -- | |
| Total Current Liabilities | -- | $2.4B | $3.9B | $2.7B | -- | |
| Long-Term Debt | -- | $1.7B | $1.9B | $2.2B | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $6.1B | $8.1B | $7B | -- | |
| Common Stock | -- | $11.9B | $11M | $11M | -- | |
| Other Common Equity Adj | -- | -- | -$48M | $54M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $41M | $44M | -- | |
| Total Equity | -- | $6.5B | $9.1B | $10.8B | -- | |
| Total Liabilities and Equity | -- | $12.6B | $17.2B | $17.8B | -- | |
| Cash and Short Terms | -- | $1B | $3.1B | $2.9B | -- | |
| Total Debt | -- | $2.1B | $2.1B | $2.4B | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.4B | -$1.4B | -$254M | $1.4B | $1B | |
| Depreciation & Amoritzation | $2.7B | $2.5B | $1.6B | $1.6B | $1.5B | |
| Stock-Based Compensation | -- | $1M | $223M | $181M | $150M | |
| Change in Accounts Receivable | -$143.7M | $753M | -$387M | $35M | -$169M | |
| Change in Inventories | -$42.3M | -$560M | -$202M | -$261M | -$148M | |
| Cash From Operations | $496.8M | $1B | $2.8B | $2.6B | $2.1B | |
| Capital Expenditures | $772.8M | $592M | $1.8B | $3.1B | $1.8B | |
| Cash Acquisitions | $832.6M | $111M | -- | -- | $236M | |
| Cash From Investing | $343.7M | -$366M | -$1.5B | -$4.1B | -$1.9B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.8B | $2.8B | $617M | $971M | $46M | |
| Long-Term Debt Repaid | -$3.8B | -$3.8B | -$1.5B | -$390M | -$305M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $307.2M | $311M | $117M | $93M | $5M | |
| Cash From Financing | -$683.8M | -$733M | $650M | $842M | -$212M | |
| Beginning Cash (CF) | $844M | $997M | $908M | $2.9B | $2.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $156.7M | -$95M | $2B | -$592M | $31M | |
| Ending Cash (CF) | $997.3M | $908M | $2.9B | $2.4B | $2.4B | |
| Levered Free Cash Flow | -$276M | $412M | $1.1B | -$435M | $321M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $5M | $336M | $249M | $178M | |
| Depreciation & Amoritzation | -- | $416M | $395M | $366M | $396M | |
| Stock-Based Compensation | -- | $25M | $33M | $41M | $50M | |
| Change in Accounts Receivable | -- | $127M | $71M | -$198M | -$141M | |
| Change in Inventories | -- | -$72M | -$80M | -$5M | -$17M | |
| Cash From Operations | -- | $1.1B | $679M | $416M | $375M | |
| Capital Expenditures | -- | $393M | $613M | $324M | $162M | |
| Cash Acquisitions | -- | -- | -- | -- | -$69M | |
| Cash From Investing | -- | -$362M | -$764M | -$313M | -$263M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $164M | $169M | $2M | $29M | |
| Long-Term Debt Repaid | -- | -$692M | -$74M | -$57M | -$39M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -$525M | $157M | -$54M | -$12M | |
| Beginning Cash (CF) | -- | $805M | $2.5B | $1.8B | $2.2B | |
| Foreign Exchange Rate Adjustment | -- | -$9M | -$5M | -$1M | $2M | |
| Additions / Reductions | -- | $223M | $72M | $49M | $100M | |
| Ending Cash (CF) | -- | $1B | $2.5B | $1.9B | $2.3B | |
| Levered Free Cash Flow | -- | $717M | $66M | $92M | $213M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $820M | $1.4B | $745M | |
| Depreciation & Amoritzation | -- | -- | $1.6B | $1.5B | $1.6B | |
| Stock-Based Compensation | -- | $169M | $191M | $164M | $173M | |
| Change in Accounts Receivable | -- | -- | -$231M | -$142M | $54M | |
| Change in Inventories | -- | -- | -$265M | -$210M | -$294M | |
| Cash From Operations | -- | -- | $3.3B | $1.9B | $1.9B | |
| Capital Expenditures | -- | $1.1B | $2.7B | $2.6B | $718M | |
| Cash Acquisitions | -- | -- | -- | $238M | -$71M | |
| Cash From Investing | -- | -- | -$3.6B | -$2.8B | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $800M | $405M | $29M | |
| Long-Term Debt Repaid | -- | -- | -$548M | -$322M | -$270M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | $1.9B | $235M | -$420M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $1.5B | -$671M | $401M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | $563M | -$635M | $1.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$296M | $778M | $740M | $467M | |
| Depreciation & Amoritzation | -- | $1.2B | $1.2B | $1B | $1.2B | |
| Stock-Based Compensation | -- | $169M | $137M | $120M | $143M | |
| Change in Accounts Receivable | -- | -$119M | $37M | -$140M | $83M | |
| Change in Inventories | -- | -$158M | -$221M | -$170M | -$316M | |
| Cash From Operations | -- | $1.7B | $2.1B | $1.4B | $1.3B | |
| Capital Expenditures | -- | $1.1B | $2.1B | $1.6B | $490M | |
| Cash Acquisitions | -- | -- | -- | $238M | -$69M | |
| Cash From Investing | -- | -$824M | -$3B | -$1.8B | -$1B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $429M | $612M | $46M | $29M | |
| Long-Term Debt Repaid | -- | -$1.3B | -$286M | -$218M | -$183M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$200M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -$749M | $482M | -$125M | -$333M | |
| Beginning Cash (CF) | -- | $2.3B | $8.7B | $6.4B | $6.8B | |
| Foreign Exchange Rate Adjustment | -- | -$8M | -$6M | -$1M | -- | |
| Additions / Reductions | -- | $119M | -$392M | -$471M | -$101M | |
| Ending Cash (CF) | -- | $2.5B | $8.3B | $6B | $6.7B | |
| Levered Free Cash Flow | -- | $574M | $65M | -$135M | $775M | |
Get GFS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GFS
Sector
P/E ratio
31.13x
25.31x
PEG ratio
--
0.06x
P/B ratio
2.05x
2.37x
Price / LTM sales
3.43x
1.88x
Growth Metrics
GFS
Sector
Revenue growth
-6.1%
4.2%
Earnings growth
-28.89%
9.52%
Revenue (5-year growth)
3.59%
6.47%
Earnings forecast
$0.33
$0.12
Profitability
GFS
Sector
Profitability FY 2023
$2.1B
$100.9M
Return on invested capital
5.51%
1.74%
Return on assets
4.11%
0.52%
Return on equity
7.38%
2.9%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
13
Estimated Next Earnings Date
Feb
4
Balance Sheet
GFS
Sector
Total cash
$3.4B
$58.4M
Short term investments
$1.1B
$27.5M
Total assets
$18B
$285.5M
Long term debt
--
$4.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 2.79% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.8% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.31% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
